Pharma & Drugs
Share your love
Glaucoma techniques advance with innovative viscoelastic delivery
(Image Credit: AdobeStock/rohane) “Modern devices for delivering viscoelastics during viscocanaloplasty have changed greatly over the past few years, resulting in better outcomes with improved ergonomics and user-friendliness for the surgeons who are performing the procedures,” said Edward Yung, MD, of…
Inside the CCOI Myopia Workshop with Assoc Prof Daniel Ting
The CCOI Myopia Workshop in Paris on September 8, 2025, will bring together global experts to address the rising epidemic of myopia. (Image credit: AdobeStock/racesy) As myopia rates continue to climb globally—emerging as a major concern not only in Asia…
identifeye HEALTH launches retinal screening platform
Demonstration of the identifeye HEALTH device in use. Photo owned by identifeye HEALTH and used with permission identifeye HEALTH has launched its retinal screening platform and is now delivering results to patients through clinics and community programs. The platform is…
The potential of AI in retina with Daniela Ferrara
This conversation features Daniella Ferrara, Chief Medical Officer for TopCon Healthcare, discussing the transformative potential of artificial intelligence in retinal imaging and ophthalmology. Ferrara, an ophthalmologist and retina specialist with 25 years of experience in retinal imaging innovation. The discussion…
Kriya Therapeutics raises $313.3 funding
(Image credit: ©Hand Robot/AdobeStock) Kriya Therapeutics reported in an SEC filing it has raised $313.3 million in a recent funding round.1 The filing does not detail fund specificity or funding sources but rather only states two investors participated in the…
European Commission approves aflibercept biosimilar Mynzepli
AVT06, now approved for marketing in the EU as Mynzepli, is also under regulatory review in the United States and Japan. Image credit: ©artjazz – stock.adobe.com Advanz Pharma and Alvotech announced that the European Commission (EC) has approved marketing authorization for…
Nicox releases topline data from phase 3 Denali trial of NCX 470 in open-angle glaucoma or ocular hypertension patients
(Image Credit: AdobeStock/Naypong Studio) Nicox has announced that the phase 3 Denali trial of NCX 470 0.1% met the primary endpoint of non-inferiority in lowering intraocular pressure (IOP) from baseline in open-angle glaucoma or ocular hypertension patients compared to the…
FDA extends target action date for two Regeneron regulatory submissions to Q4 of 2025
(Image Credit: AdobeStock/Ascannio The US Food and Drug Administration (FDA) has extended the target action dates for Regeneron Pharmaceuticals’ 2 EYLEA HD (aflibercept) Injection 8 mg regulatory submissions to the fourth quarter of 2025. The 2 regulatory submissions include a Chemistry, Manufacturing,…
VivaVision Biotech appoints Quan Dong Nguyen to its scientific advisory board
(Image credit: AdobeStock) VivaVision Biotech Co., Ltd., appointed Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS, to its scientific advisory board. Nguyen is a professor of ophthalmology at the Byers Eye Institute, Stanford University School of Medicine. He is also…
The emerging era of presbyopia-correcting eye drops: What’s next?
(Image Credit: AdobeStock/taffpixture) Since 2021, only 1 prescription eye drop for the correction of presbyopia, pilocarpine HCI ophthalmic solution 1.25% (Vuity; AbbVie), has been available, with additional options expected soon. In early 2025, a second eye drop, pilocarpine HCI ophthalmic…